Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Retatrutide Retatrutide is a triple agonist (GIP/GLP-1/glucagon receptor) currently in late-stage clinical trials that has shown remarkable weight loss results of up to 24% in Phase 2 studies
Tinelli C, Di Pino A, Ficulle E, Marcelli S, Feligioni M
"I learned that it had a lot to do with me trying to eat my normal intake of food," shared one patient
Moreover, many of them must deal with the scars that come after
Oral kits may be considered when you prefer not to inject, you do not meet GLP-1 eligibility criteria, cost is a significant factor, or your clinician determines the oral combination is better suited to your health profile
US$ 26.70
US$ 29.29
US$ 23.40
US$ 26.12
US$ 21.81
US$ 20.73
